Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases. In a Perspective in Cell Metabolism, the researchers first highlight the dysregulation of hepatokines – proteins released from the liver – in people with NAFLD. Then, they discuss pathomechanisms of type 2 diabetes and cardiovascular diseases specifically related to NAFLD by focusing on hepatokine-related organ crosstalk. Finally, they propose how the determination of major hepatokines and adipokines (proteins released from fat) can be used for the identification of subtypes of people with NAFLD, to better implement precision medicine in clinical practice.
Worldwide more than 25% of adults and 3-10% of children have NAFLD. The percentage of NAFLD is much higher when obesity and/or diabetes is present in adults (60%) and in children (⁓40%). These numbers are alarming, because NAFLD, and more so non-alcoholic steatohepatitis, is the main cause of chronic liver disease and liver cancer. Furthermore, results from large studies reveal that NAFLD associates with ⁓2.5-fold increased risk of type 2 diabetes and ⁓1.5-fold increased risk of cardiovascular events. But what are the mechanisms by which the fatty liver impacts on the genesis of type 2 diabetes and cardiovascular diseases? Furthermore, how can the impact of fatty liver be separated from the impact of increased abdominal obesity, which is often found in people with fatty liver, on these diseases?
The researchers have been studying these questions since many years. They have identified important hepatokines that are dysregulated in NAFLD and have described their role in metabolism.
‘We found that the hepatokine fetuin-A is increasingly produced by the fatty liver and that it strongly predicts the incidence of type 2 diabetes and cardiovascular events. We also identified mechanisms of cellular action of fetuin-A to promote insulin resistance, subclinical inflammation and impairment of insulin secretion’, highlights the author and adds: ‘We identified another important hepatokine which is increasingly produced by the fatty liver – follistatin. We found mechanisms up-regulating the production of follistatin in the liver and identified the mechanisms by which follistatin increases glucose levels and insulin resistance. In large human cohorts we found that follistatin associates with an increased risk of type 2 diabetes’.
In their present article the researchers describe the mechanisms of action of these hepatokines and summarize knowledge about other hepatokines that are being studied in the scientific community.
Finally, the researchers made use of a currently very popular research tool – cluster analysis, a data dimensionality reduction approach – to disentangle the close relationship between fatty liver and abdominal obesity and to identify subtypes of people with fatty liver.
Clustering the parameters liver fat content, visceral fat mass, the hepatokine fetuin-A and the adipokine adiponectin, they identified 3 clusters. The clusters 1 and 3 had similar insulin resistance and elevated liver fat content but largely differed in the plasma levels of fetuin-A and adiponectin.
The researchers concluded that they identified subtypes of people with fatty liver having different pathomechanisms of insulin resistance and that the research into hepatokines may be helpful to find other subtypes of fatty liver in the future.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(23)00006-2
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fthe-role-of-hepatokines&filter=22
The role of hepatokines in NAFLD
- 960 views
- Added
Latest News
How molecules in a cell int…
By newseditor
Posted 02 Dec
Genetic programmes underlie…
By newseditor
Posted 01 Dec
APOE variant neurons releas…
By newseditor
Posted 01 Dec
Reducing vitamin B5 slows b…
By newseditor
Posted 01 Dec
Mouse brain is 'rewired' du…
By newseditor
Posted 01 Dec
Other Top Stories
Regulation of remyelination by endothelin receptor
Read more
Mechanism of synapse elimination in Alzheimer's disease
Read more
Visual stress could be a symptom of Chronic Fatigue Syndrome
Read more
How can I tell if she's lying?
Read more
DNA repair factor BRCA1 depletion occurs in Alzheimer brains and im…
Read more
Protocols
Temporally multiplexed imag…
By newseditor
Posted 02 Dec
Efficient elimination of ME…
By newseditor
Posted 01 Dec
Personalized drug screening…
By newseditor
Posted 30 Nov
Multi-chamber cardioids unr…
By newseditor
Posted 29 Nov
Microfluidic-based skin-on-…
By newseditor
Posted 28 Nov
Publications
APOE4-promoted gliosis and…
By newseditor
Posted 01 Dec
Sensory neuronal STAT3 is c…
By newseditor
Posted 01 Dec
Vitamin B5 supports MYC onc…
By newseditor
Posted 01 Dec
Longitudinal evolution of d…
By newseditor
Posted 01 Dec
Pre-RNA splicing in metabol…
By newseditor
Posted 01 Dec
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar